Related Experiment Video
Updated: Jun 20, 2026

Isolation of Mesenchymal Stem Cells from Human Alveolar Periosteum and Effects of Vitamin D on Osteogenic Activity of Periosteum-derived Cells
Published on: May 4, 2018
Vimentin inhibits ATF4-mediated osteocalcin transcription and osteoblast differentiation
Na Lian1, Weiguang Wang, Lingzhen Li
1Department of Medicine, Vanderbilt University Center for Bone Biology, Vanderbilt University Medical Center, Nashville, Tennessee 37232, USA.
Abstract:
Activating transcription factor 4 (ATF4) is an osteoblast-enriched transcription factor that regulates osteocalcin transcription and osteoblast terminal differentiation. To identify functional partners of ATF4, we applied ROS17/2.8 osteoblast nuclear extracts and purified recombinant His-ATF4 onto a Ni(+) affinity matrix chromatography column. Vimentin was identified by liquid chromatography-mass spectrometry. Coimmunoprecipitation and pulldown assays revealed that vimentin interacted with ATF4 with its first leucine zipper domain. DNA cotransfection and gel retardation demonstrated that vimentin inhibited the transactivation activity of ATF4 on osteocalcin by preventing it to bind OSE1, the ATF4 binding site on the osteocalcin promoter. Northern hybridization revealed that vimentin was expressed at a high level in immature osteoblasts and a low level in fully differentiated osteoblasts. Down-regulation of vimentin by small interfering RNA induced endogenous osteocalcin transcription in immature osteoblasts. Conversely, ectopic overexpression of vimentin in osteoblasts inhibited osteoblast differentiation as shown by lower alkaline phosphatase activity, delayed mineralization, and decreased expression of osteoblast marker genes such as bone sialoprotein and osteocalcin. Together, our data uncover a novel mechanism whereby a cytoskeletal protein, vimentin, acts as a break on differentiation in immature osteoblasts by interacting with ATF4.
Insights
Vimentin, a cytoskeletal protein, binds to Activating Transcription Factor 4 (ATF4) and inhibits osteoblast differentiation. Reducing vimentin levels promotes osteocalcin transcription in immature bone cells.
Area of Science:
- Molecular Biology
- Cell Biology
- Biochemistry
Background:
- Activating transcription factor 4 (ATF4) is crucial for osteoblast differentiation and osteocalcin gene regulation.
- Identifying ATF4's functional partners is key to understanding osteoblast biology.
Purpose of the Study:
- To identify proteins interacting with ATF4 in osteoblasts.
- To elucidate the functional role of identified partners in ATF4-mediated osteoblast differentiation.
Main Methods:
- Affinity chromatography using recombinant His-ATF4 and osteoblast nuclear extracts.
- Liquid chromatography-mass spectrometry for protein identification.
- Coimmunoprecipitation, pulldown assays, DNA cotransfection, gel retardation, Northern hybridization, and small interfering RNA (siRNA) for functional validation.
Main Results:
- Vimentin was identified as an ATF4-interacting protein, binding via ATF4's leucine zipper domain.
- Vimentin inhibits ATF4's transactivation of osteocalcin by blocking ATF4 binding to the OSE1 site.
- Vimentin expression is high in immature osteoblasts and low in mature osteoblasts.
- Vimentin knockdown enhances osteocalcin transcription in immature osteoblasts.
- Vimentin overexpression impairs osteoblast differentiation markers (alkaline phosphatase, mineralization, bone sialoprotein, osteocalcin).
Conclusions:
- Vimentin acts as a negative regulator of osteoblast differentiation.
- Vimentin interacts with ATF4 to suppress osteocalcin expression and inhibit terminal differentiation in immature osteoblasts.
- This interaction represents a novel mechanism controlling osteoblast maturation.
Related Concept Videos
TGF - β Signaling Pathway
Osteoclasts in Bone Remodeling
Regulation of Angiogenesis and Blood Supply
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
Bone Remodeling and Repair
